title: Increased mRNA expression of a laminin-binding protein in human colon carcinoma: complete sequence of a full-length cDNA encoding the protein.
abstract: Reliable markers to distinguish human colon carcinoma from normal colonic epithelium are needed particularly for poorly differentiated tumors where no useful marker is currently available. To search for markers we constructed cDNA libraries from human colon carcinoma cell lines and screened for clones that hybridize to a greater degree with mRNAs of colon carcinomas than with their normal counterparts. Here we report one such cDNA clone that hybridizes with a 1.2-kilobase (kb) mRNA, the level of which is approximately equal to 9-fold greater in colon carcinoma than in adjacent normal colonic epithelium. Blot hybridization of total RNA from a variety of human colon carcinoma cell lines shows that the level of this 1.2-kb mRNA in poorly differentiated colon carcinomas is as high as or higher than that in well-differentiated carcinomas. Molecular cloning and complete sequencing of cDNA corresponding to the full-length open reading frame of this 1.2-kb mRNA unexpectedly show it to contain all the partial cDNA sequence encoding 135 amino acid residues previously reported for a human laminin receptor. The deduced amino acid sequence suggests that this putative laminin-binding protein from human colon carcinomas consists of 295 amino acid residues with interesting features. Containing only two cysteine residues, the protein does not have consensus sequences for asparagine-linked glycosylation, amphipathic alpha-helix, or the N-terminal leader signal sequences for entry into endoplasmic reticulum, although hydrophobic segments for potential membrane associations exist. There is an unusual C-terminal 70-amino acid segment, which is trypsin-resistant (no lysine or arginine) and highly negatively charged (13 aspartic plus glutamic residues). Within this segment are five repeats of (Asp/Glu)-Trp-(Ser/Thr); two of these are nearly tandem repeats of Thr-Glu-Asp-Trp-Ser-Ala-Xaa-Pro.
authors.affiliation: Dana-Farber Cancer Institute, New England Deaconess Hospital, Boston, MA.
authors.forename: H K
authors.initials: HK
authors.lastname: Yow
authors.forename: J M
authors.initials: JM
authors.lastname: Wong
authors.forename: H S
authors.initials: HS
authors.lastname: Chen
authors.forename: C G
authors.initials: CG
authors.lastname: Lee
authors.forename: S
authors.initials: S
authors.lastname: Davis
authors.forename: G D
authors.initials: GD
authors.lastname: Steele
authors.forename: L B
authors.initials: LB
authors.lastname: Chen
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D002460:Cell Line; D003110:Colonic Neoplasms / Q000276:immunology*; D004273:DNA, Neoplasm / Q000235:genetics; D006801:Humans; D007797:Laminin / Q000378:metabolism; D008969:Molecular Sequence Data; D009693:Nucleic Acid Hybridization; D010957:Plasmids; D012333:RNA, Messenger / Q000235:genetics*; D011971:Receptors, Immunologic / Q000235:genetics*; D017474:Receptors, Laminin; D014158:Transcription, Genetic; D014407:Tumor Cells, Cultured / Q000276:immunology*
chemical_list: D004273:DNA, Neoplasm; D007797:Laminin; D012333:RNA, Messenger; D011971:Receptors, Immunologic; D017474:Receptors, Laminin